Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$10.01 Mil
% of Total Estimate Gain
45.29%

Checkpoint Capital L.P.'s Axsome Therapeutics Inc Holding Summary

As of 2025-03-31, Checkpoint Capital L.P. held - shares of Axsome Therapeutics Inc(AXSM), totaling N/A. This investment constitutes 0% of their stock portfolio, and Checkpoint Capital L.P. now holds 0% of the outstanding Axsome Therapeutics Inc(AXSM) stock.

The initial trade took place in 2023Q4. And since then Checkpoint Capital L.P. has made 1 purchases of AXSM, at an average price of $70.48, for a total of 313,681.00 shares. In addition, there have been 4 sales at an average price of $102.41 for 313,681.00 shares. Based on historical transaction data and AXSM's current price of $105.44, Checkpoint Capital L.P.'s estimated gain on his AXSM holdings is $10.01 Mil, reflecting a 45.29% gain to date.

Checkpoint Capital L.P. AXSM ($105.44) Holding Chart

Checkpoint Capital L.P. AXSM ($105.44) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1